Navigation Links
Chimerix Completes Phase I Study and Initiates a Phase II Multi-dose Clinical Trial for CMX001
Date:1/6/2009

RESEARCH TRIANGLE PARK, N.C., Jan. 6 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, announced today that the Company has completed a single and multi-dose Phase I study of CMX001 in healthy volunteers. This study supports the further development of the drug for multiple dsDNA infections. The Company has initiated the first Phase II multi-dose clinical trial in patients.

"The safety and high oral availability demonstrated by CMX001 in the Phase I trial has exceeded our original expectations," said Dr. George Painter, Chimerix President and CEO. "We believe that CMX001 has potential for prevention and treatment of many serious and potentially fatal infections such as smallpox, cytomegalovirus, BK virus and adenovirus."

The Phase I study of CMX001 was a blinded, randomized, placebo-controlled study that evaluated the safety and pharmacokinetics of orally administered CMX001 in healthy volunteers. The study found CMX001 to be well tolerated at all doses in 84 healthy volunteers.

The first Phase II trial will study the effects of multiple doses of CMX001 given to stem cell and kidney transplant recipients with BK viruria, a condition which may eventually lead to loss of the kidney graft, or to uncontrolled bleeding in the bladder. Further studies are planned to explore the ability of CMX001 to prevent cytomegalovirus disease, a viral disease that may lead to blindness or severe gastrointestinal disease after bone marrow transplant.

CMX001 is being developed for the treatment of smallpox infection and other double stranded DNA virus infections that cause significant human morbidity and mortality. A safe, orally active antiviral drug to treat smallpox infection is needed to help people who become ill after exposure to the disease or those who cannot be vaccinated. The work is partially funded by a $36.1 million grant
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Chimerix Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer
2. Merial to Screen Chimerix Chemical Library for Animal Health Drug Leads
3. H2Diesel Completes 3 Million Gallon Per Year Pilot Facility
4. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Carrington Completes $8 Million Financing
7. Proteon Therapeutics Completes $12 Million Financing and Hires CFO
8. New Brunswick Scientific Completes Merger Transaction with Eppendorf
9. Kiwa Bio-Tech Completes 1st Stage of Shandong Factory Upgrading
10. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
11. Optherion, Inc. Completes $37 Million Start Up Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... -- Calcivis, a medical devices company ... today announces that it has completed a first ... System. The Calcivis Caries Activity Imaging ... combination designed to transform the assessment and management ... unique, proprietary bioluminescence approach combined with a specialised ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 The ... and segments the market for detailed analysis of ... the market to reach $616.3 million by 2018, ... to 2018. , Browse through the TOC of ... to get an idea of the in-depth analysis ...
(Date:11/26/2014)... Baltimore, MD (PRWEB) November 26, 2014 ... invite the Baltimore and Washington D.C. science community ... research. , The event, sponsored by the Protein Society, ... in UMBC’s University Center, Room 312. Through discussion, ... functional and structural importance of proteins, their role in ...
(Date:11/26/2014)... (PRWEB) November 25, 2014 Silicon Valley ... forces with RPM Alliance , provider of clinical ... companies. With the latest addition to its CRO Partnership ... validated EDC system to India. , “We have ... robust and customizable EDC platform which is both user ...
Breaking Biology Technology:Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 2Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 3The North America Thermal Protective Clothing Market is estimated to grow up to $616.3 million by 2018 - Report by MicroMarket Monitor 2The North America Thermal Protective Clothing Market is estimated to grow up to $616.3 million by 2018 - Report by MicroMarket Monitor 3RPM Alliance Joins Clinovo’s CRO Partnership Program, Further Strengthening Its Presence in Southern California and India 2
... millions of Americans whose vision is slowly ebbing due to degenerative ... riding to the rescue. , ,In a study in rats, neural ... to protect the vision of animals with degenerative eye disease similar ... appears in the journal Public Library of Science (PLoS) ...
... the launch of a new laptop-sized ultrasound system, ... in the compact ultrasound industry in 2006, according to ... Consultants . , ,Klein Biomedical, which tracks ultrasound market ... of the compact ultrasound market, with annual sales of ...
... Madison, Wis. - Gov. Jim Doyle has announced the allocation ... new ethanol plant in the Juneau County village of Necedah. , ... help Necedah construct a new well and water main that will ... will produce 50 million gallons of ethanol annually and employ between ...
Cached Biology Technology:Stem cell therapy shows visionary promise 2Stem cell therapy shows visionary promise 3GE Healthcare leads compact ultrasound market 2
(Date:11/4/2014)... – (Nov. 4, 2014) – A majority of Madagascar,s ... that could have serious consequences for the rainforests they ... shows the positive impacts lemurs can have on rainforest ... their disappearance could have on the region,s rich biodiversity. ... have fruits eaten by lemurs. Lemurs in turn ...
(Date:11/3/2014)... Colorado Cancer Center study published in this ... describes the activity of a recently discovered communication ... IL-37. It has been known to limit inflammation and ... immune system: IL-37 inhibits the ability of the immune ... this mechanism that underlies IL-37,s effect on the immune ...
(Date:11/2/2014)... In this month,s issue of Physics World , ... bridging the "valley of death" to take their innovations ... argues that the gruelling challenge facing all start-up companies ... harder for physicists because of two main factors: physics-based ... and they often turn out to be a lot ...
Breaking Biology News(10 mins):Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3PNAS: From HIV to cancer, IL-37 regulates immune system 2The 'valley of death' facing physics start-ups 2
... A new species of monkey flower, created by the ... bank of a stream in Scotland. Genetic changes in this attractive ... a rare example of a brand new species that has originated ... species and some crops are thought to have originated in this ...
... Calif.) Despite the ever-louder drumbeat for sustainability and ... a collision course with "unprecedented levels of damage and ... assessment that includes UC Santa Barbara researchers among its ... Global Environmental Outlook report commonly known as GEO-5 ...
... occurring protein called TLR1 plays a critical role in ... pork or drinking contaminated water, according to new research ... discovery may help create more effective oral vaccines for ... has launched an examination of how TLR1 is linked ...
Cached Biology News:Rare glimpse into the origin of species 2UC Santa Barbara researchers play key role in UN Environmental Assessment 2UC Santa Barbara researchers play key role in UN Environmental Assessment 3TLR1 protein drives immune response to certain food-borne illness in mice 2
... and temperature control for microbiology and cell ... and is suitable for DASGIP bioreactors from ... Its temperature ranges from approximately 10 °C ... equipped with an individual electrical heating element ...
... records analyzes and reports the data from any ... the a chart recorder. The final data is ... The end-point selection is automatic for Systolic, Mean, ... computed. The user is always in the position ...
... Custom DNA microarrays designed for your ... and powerful Paraflo microfluidic synthesis platform. Thousands ... on-chip and LC Sciences can provide assistance ... available as part of our comprehensive Custom ...
... aptamer screening and binding optimization and built ... on-chip synthesis platform. These microarrays are available ... Microarray Service. Probe Content ... greater than 1500 known aptamer sequences. Add ...
Biology Products: